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Long-term results in the treatment of fistula-in-ano with 
fibrin glue: a prospective study
Göktürk Maralcan, İlyas Başkonuş, Avni Gökalp, Ersin Borazan, Ahmet Balk
Department of General Surgery, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Purpose: This prospective study was done to analyze the efficacy of commercial fibrin glue application in the healing of pa-
tients with fistulas-in-ano from a long-term (mean 4.5 years) research period. Methods: This clinical trial of forty-six patients 
was performed during the period from January 2004 to February 2005. Thirty-nine men and seven women were treated for a 
fistula-in-ano with a commercial fibrin glue application. In the operating room, the patients underwent an anorectal exami-
nation under spinal anesthesia. The external and internal fistula tract openings were then identified. The fistula tract was 
curetted. Fibrin glue was injected into the external fistula opening until the fibrin glue could be seen coming from the internal 
opening. Results: The overall initial success rate was 86.95% (40/46). Recurrence rate was 41.30% (19/46). Two patients under-
went a re-application with fibrin glue and the fistulas of these patients closed. The total recurrence rate was 36.95% (17/46). 
The long-term overall success rate was 63.04% (29/46). Conclusion: Fibrin glue application was thus found to be an easy, safe, 
acceptable, successful alternative treatment in the management of fistulas-in-ano. Choosing the patient correctly is very im-
portant because long (more than 4 cm) and non-ramificate fistula tracts usually close with commercial fibrin glue.
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INTRODUCTION
Many techniques for fistula-in-ano treatment have been 
reported. The goal of surgical treatment of a fistula-in-ano 
is to heal the fistula tract with the lowest rate of recurrence 
while still maintaining continence. The standard surgical 
treatment of fistulas-in-ano is an anal fistulotomy, which 
involves laying open the fistula tract and any associated 
sphincter muscle. Despite being properly performed, fis-
tulotomy wounds can have prolonged healing times 
which can result in contour defects around the anus and 
they can also cause postoperative discomfort [1]. The other 
techniques (seton application, flap, etc) also have a long 
treatment period and are skilled operative techniques. In 
addition, Lunniss et al. [2] have shown that even a minimal 
division of the anal sphincter muscle during a fistulotomy 
can be associated with changes in fecal continence. Given 
these results, investigators have thus sought simpler 
sphincter muscle-sparing techniques to treat fistulas- 
in-ano [1]. 
Recently, the use of tissue adhesives or sealants in sur-
gery has increased because of improved  autologous and Göktürk Maralcan, et al.
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Table 1. Patient characteristics and fistulae duration
Patient characteristics Value
Gender, n (%)
　Male  39 (84.78)
    Female   7 (15.21)
Age, mean (range) 33 yr (16-59 yr)
Fistula duration
　Minimum     4 mo
    Maximum 10 yr
commercially available products [1,3-5]. Fibrin glue appli-
cation can be a valuable adjunct to surgical procedures in 
the treatment of fistula-in-ano. Fibrin glue is a biological 
glue made up of fibrinogen and its multiple components 
[6]. The end product is a gel-like substance that can be used 
in surgery to achieve hemostasis and a water tight seal [7]. 
The purpose of this study was to ascertain the effective-
ness of commercially available fibrin glue in closing fistu-
la-in-ano at the long-term period.
METHODS
This prospective clinical study was carried out on 47 pa-
tients undergoing commercial fibrin glue application in 
the Department of General Surgery in Gaziantep Univer-
sity Faculty of Medicine between January 2004 and Fe-
bruary 2005. Any patients with intersphincteric fistulas, 
rectovaginal fistulas, Crohn’s disease and fistulas-in-ano 
associated with chronic cavities, acute sepsis, or side- 
branches were excluded. To outline the extent of the fistu-
lous tract, a fistulography was performed on patients with 
suspicious complicated fistulas. Patients with a ram-
ification of the fistulae demonstrated by X-ray were 
excluded. One patient was excluded because of a follow- 
up problem. Forty-six patients were thus included in the 
study. Thirty-nine men and seven women were treated for 
a fistula-in-ano. Their mean age was 33 years (range, 16 to 
59 years). The duration of persistent fistulae ranged from 4 
months to 10 years. The patient characteristics and fistulae 
duration are shown in Table 1. 
The study was designed and conducted according to 
the guidelines of the Helsinki Declaration  [8] and was ap-
proved by the local ethics committee. Detailed informed 
consent was obtained from all patients. 
Preoperatively, none of the patients complained of any 
degree of fecal incontinence. All patients were managed 
under normal inpatient procedures. Anamnesis was 
performed. A careful physical examination confirmed the 
diagnosis of  fistulas-in-ano in each patient.  Each patient 
was instructed to use a mechanical bowel preparation 
with polyethylene glycol or sodium phosphate, one day 
before the application of the fibrin glue injection. All pa-
tients received prophylactic parenteral antibiotics (cefu-
roxime, 1.5 g; ornidazole, 500 mg). The anorectal examina-
tion and fibrin glue application were performed in the op-
erating room. The procedure was carried out under spinal 
anesthesia. Operating time was recorded between the in-
jection of the spinal anesthesia and a visual of the glue 
bubble at the external orifice of the fistula. 
All applications were performed by the same surgical 
team on each patient. During the examination, under spi-
nal anesthesia in the prone jackknife position the fistula 
was probed gently to identify any external and internal fis-
tula tract openings. The external and internal openings of 
the fistula tract were identified in all patients. The length 
of the fistula tract was measured (according to the length 
of probe in the fistula tract) and noted. We planned the 
comparison of the length of the fistula tract of the ‘recur-
rence’ patients and the ‘treatment’ patients. The tract was 
curetted with polyester tape (white braided fiber, pre-cut 
lengths 1/8" wide; Sherwood Medical, St. Louis, MO, 
USA), which was tied with a few knots on itself. Extensive 
debridement was unnecessary, but the granulation tissue 
was removed, then cleaned out with normal saline. The fi-
brin glue from a commercial kit was retrieved from stor-
age at 4
oC and then allowed to reach room temperature 
over an approximately one-hour period. The fibrin glue 
was prepared according to the manufacturer’s recom-
mendations (Beriplast P, Aventis Behring, Marburg, Ger-
many). In short, the fibrin glue consisted of two compo-
nents: fibrinogen concentrate and thrombin. Fibrin glue 
mimics the last step of blood clotting. Factor XIII is added 
as an adjuvant and stabilizes the fibrin monomers. Aproti-
nin is added as an adjuvant and prevents fibrinolysis. 
Fibrin glue was then instilled into the fistula tract by Fibrin glue in the treatment of fistula-in-ano
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way of an external opening so its tip was seen emerging 
from the internal opening into the anal canal. The injection 
was performed through a double-channel tube (syringe) 
with an infant feeding tube (Size, 5 or 6 F; Romsons 
International, Nunhai, Indıa), which was prepared ac-
cording to the fistula tract length, and with the anal re-
tractor in place. The tube had been introduced to the bot-
tom of the fistula-in-ano and then was continuously with-
drawn during the injection so that the fistula was com-
pletely filled with fibrin glue (this generally required less 
than 1 commercial fibrin glue product, consisting of ap-
proximately 2 mL glue). If the tract was long, two fibrin 
glue products were prepared and used. Once a bubble of 
instantly solid glue was seen at the internal opening, it was 
considered that the first part of the tract was filled. Then 
both the feeding tube and the syringe were slowly and 
steadily withdrawn while the glue continuing to be dis-
charged. This application filled the tract with glue until the 
tube emerged at the external opening, where another bub-
ble of glue was seen on the perianal skin. No dressing was 
applied on the external opening. The glue was allowed to 
become even more stable and solid over a little less than 
approximately one minute, and the anal retractor was re-
moved, while being careful not to catch the internal bubble 
on the retractor and thus dislodge the plug. 
Postoperative analgesic requirements were followed 
up. Complications were considered early if the occurrence 
was within one month of application, and late if the occur-
rence was after one month. The postoperative oral intake 
was restricted for one day. Thereafter, the patients were 
placed on a liquid diet for 24 hours and then gradually ad-
vanced to a regular diet. They received oral cefuroxime 
(250 mg twice daily) and ornidazole (500 mg a day) for one 
week. The length of hospital stay for each patient was also 
recorded. Patients were discharged the first day after their 
fibrin glue application. Sitz baths were prohibited for fear 
of dislodging the fibrin glue plug. 
All patients were evaluated at each follow-up visit. 
Questions included whether they had any perirectal 
drainage, pain, or evidence of a failed fistula closure. It is 
generally considered that if the application was success-
ful, then the effect of the treatment is immediate, with ei-
ther a complete cessation or a significant reduction in 
drainage. The patients were asked a series of questions re-
garding their experience of the length of limitation in nor-
mal activities and work. Physical examinations were also 
conducted with each subsequent clinic visit. Outpatient 
and telephone visit follow-up examinations were per-
formed for all patients ranging from 4 to 5 years with a 
mean of 4.5 years. Therefore telephone visits were partic-
ularly useful in the long-term. If the fistula failed to heal 
with primary treatment fibrin glue at follow-up or had 
healed and then subsequently recurred, the patient was in-
vited for another glue treatment if appropriate. Repeated 
fibrin glue injections were re-applied when there was a 
failure of treatment or clinical recurrence provided the pa-
tient agreed. Patients were instructed to notify their physi-
cians if they suspected a recurrence anytime during their 
postoperative course. 
RESULTS
Over a five-year period, 46 consecutive patients were 
treated with commercial fibrin glue. The cause of the fistu-
la-in-ano was cryptoglandular in all patients. All of the pa-
tients had one fistula tract. Forty-two (91.30%) of the fistu-
las were transsphincteric, and 4 (8.69%) were suprasphinc-
teric. The average length of the fistula tracts were 5.4 cm 
with a range from 4.1 to 13.2 cm. 
Our initial success rate was 40 of 46 closures (86.95%). 
They were transspincteric and suprasphincteric, 37 
(88.09%) and 3 (75.00%), respectively. A second injection 
was needed in six patients (13.00%) because fistulas re-
curred between 2 and 9 weeks. All recurrence cases were 
transsphincteric except one. All recurrence patients were 
offered another attempt at fistula sealing using fibrin glue. 
Only two patients accepted the second application. One of 
these had a low transsphincteric fistula, and the other had 
a high transsphincteric fistula. These two patients under-
went a second application of fibrin glue, thus resulting in 
a total resolution of the symptoms and a healing of the fis-
tulous tracts. Repeated fibrin glue treatments were suc-
cessful for both patients. 
The other 4 patients refused the second fibrin glue 
application. They elected another technique. They under-Göktürk Maralcan, et al.
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Fig. 1. Kaplan Meier curve for recurrence cases
Fistula type
Total no. of 
cases
Initial 
success rate
Overall 
success rate
Transsphincteric    42 (91.30) 37 (88.09) 26 (61.90)
Suprasphincteric   4 (8.69)   3 (75.00)  3 (75.00)
Total 46 (100) 40 (86.95) 29 (63.04)
Values are presented as number (%).
Table 2. Treatment results
went a seton-fistulotomy as these fistulas were high trans-
sphincteric types. 
In total, 19 recurrences were observed initially. Another 
application was recommended to these patients. Two pa-
tients were accepted. In these two patients, the second ap-
plication was successful. Seton was applied to the remain-
ing 17 cases. These setons were ended with seton fistulot-
omy sooner than 4 weeks. In 4 cases, the setons were 
changed 3 times each for sufficient drainage. The treat-
ments were completed with seton fistulotomy at approx-
imately the 12th week. For almost all recurred patients, the 
length of the tract was about 4 cm. The earliest recurrence 
was the at 2nd week. The last recurrence was in the first 
year. 
None of the patients developed incontinence. No mor-
tality was observed. The mean follow-up was 4.5 years 
with a range of 4 to 6 years. The mean length of operations 
was 16 minutes with a range from 14 to 29 minutes. The 
mean hospital stay was 1 day. None of the patients needed 
analgesics for pain relief. There was no complication re-
lated to the application of commercial fibrin glue. All of 
the patients resumed normal activities within 48 hours. 
All patients could return to work within 7 days. The re-
currence rate was 41.30% (19/46) initially. Two patients un-
derwent re-application and treatments were successful. At 
the end of the long-term period (mean 4.5 years) the total 
recurrence rate was 36.95% (17/46). Initially, the recur-
rence rates were higher than those in following months. 
So, the curve of Kaplan Meier reflected these findings (Fig. 
1). The Kaplan-Meier estimator (named after Edward L. 
Kaplan and Paul Meier), also known as the product limit 
estimator, estimates the survival function from life-time 
data. In medical research, it may be used to measure the 
fraction of patients living for a certain amount of time after 
treatment. We calculated the Kaplan-Meier estimator for 
the recurrence and then graphed them as Fig. 1. We calcu-
lated the one way analysis of variance (ANOVA) to find 
the statistical differences between 2 groups to compare the 
lengths of the fistula tracts. One way ANOVA result is 
61,70. And P ＜ 0,01. Test results show statistically sig-
nificant relationships between the 2 groups. So our results 
say these two groups are different from each other. The 
overall success rate was 63.04% (29/46). Fistula treatment 
results are shown in Table 2.
DISCUSSION  
Over the years, many papers have been published on 
the use of fibrin glue in different specialties of surgery. The 
use of fibrin glue in the treatment of fistulas-in-ano was 
first reported in the early 1980’s with reasonable results 
[9,10]. Since 1991, several articles have been published 
with favorable results using fibrin glue for the treatment of 
fistulas-in-ano [11-13]. 
Complications following a surgical repair for fistu-
la-in-ano can be devastating for patients. Flatus incon-
tinence may be a minor complication for the surgeon but it 
could be very embarrassing for the patient [14]. Therefore, 
it is prudent to look for other ways in treating fistulas- 
in-ano. Fibrin glue application has been shown to be supe-
rior to conventional surgery in terms of patient comfort, 
undisturbed sphincteric function, reduced overall hospi-
tal stay, reduced postoperative analgesia requirement and Fibrin glue in the treatment of fistula-in-ano
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Study Year
Fibrin glue 
type 
Fistula type
(etiology or simple-complex)
Success rate, n (%)
Follow-up
n( % )
Maralcan et al. [3] 2006 Commercial Cryptoglandular 36 83.30 Mean  54 wk       
Singer [21]  2005 Commercial Complex 75 (3 group) 25.00
44.00
35.00
Mean 27 mo
Loungnarath  [20]  2004 Commercial Complex 39  31.00  Median 23 mo
Sentovich [15]       2003 Commercial 
  autologous
Different (cryptogl. 75%) 48 68.80 Median 22 mo
Lindsey et al. [17] 2002 Commercial Different (simple 31%) 42 63.00 
 (simple + complex) 
59.00 (cryptogl.) 
50.00 (simple)
Median 17.1 mo
Chan  et al. [18] 2002 Commercial Simple 10 60.00 Mean 26.4 wk
Sentovich [1] 2001 Commercial 
  autologous
Different (cryptogl. 65%) 20 85.00 Mean 10 mo
Park  et al. [16] 2000 Commercial Different (simple+complex) 29 69.00 Mean  6 mo
Cintron   et al. [19] 2000 Commercial 
  autologous
Different (cryptogl. 89.9%) 79 61.00 Mean  12  mo
Present study 2011 Commercial Cryptoglandular 46 63.04 Mean 4.5 yr
Table 3.  Data of  published studies of fibrin glue treatment for fistulas-in-ano
faster return to normal activities with minimum operative 
trauma and no complication [7,14,15]. Some studies which 
were performed using conventional surgery techniques 
reported fistula treatment rates from 44 to 78 percent [15]. 
The overall success rate may be low but an acceptable rate 
for success  in this study. 
Although this study has a limited number of patients it 
has a long follow-up period. It was thought these results 
could be important to support former, optimistic studies 
and new planning studies. The patients tolerated the in-
jection procedure very well, and there were no complica-
tions resulting from this treatment, and no patient had any 
change in continence. In addition, no wound pain or dis-
comfort was observed. The results regarding the advan-
tages of fibrin glue were similar to those found in the 
literature.
The heterogeneity of the clinical trials made direct com-
parisons difficult. If our results are compared with other 
similar studies, then some differences exist between the re-
sults (Table 3) [1,3,15-21]. These differences, however, may 
be explained by their patient selection, their exclusive use 
of autologous fibrin glue that has a lower fibrinogen con-
centration, differences in the standardization of these 
products, which may thus not form as strong a plug as the 
commercial fibrin sealant may have, also contributed to 
their lower success rate. Furthermore, fistula character-
istics are important factors combined with differences of 
complex or recurrent, primer and solitary, long or short. It 
is certainly possible that the success rate for treating com-
plex and recurrent fistulas-in-ano is indeed, lower, be-
cause these types of fistulas have a lot of ramifications. 
Finding the original fistula tract can also be difficult if it is 
a high level recurrent fistula. In addition, it is also possible 
that the application techniques may differ. Certainly a rel-
atively small infection within the fistula tract could dis-
lodge the fibrin glue plug and thus result in treatment 
failure. In this study, all patients had fistulas-in-ano with a 
cryptoglandular origin. Commercial fibrin glue was used. 
All of the fistulas were non-complex, primer, solitary. 
Fistulas were long (average length of fistula tract was at 
least 5.4 cm). Furthermore, in this study, no abscess or in-
fection was observed. A preoperative mechanical bowel 
preparation was performed. Preoperative antibiotic pro-
phylaxis, curettage and washing with normal saline of the 
fistula tract locally were also performed. Oral antibiotics 
were also continued during the one-week postoperative 
period. The overall success rate was thus thought to be sat-
isfactory as a result of the above reasons (fibrin glue  ad-Göktürk Maralcan, et al.
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vantages). 
There were few possible failure factors, all or some of 
which may play a role in faster fibrin clot dissolution and 
failure. There are several possible explanations that may 
contribute to failures following sealing: lack of  radiologic 
tests of fistula and fistulography to detect the extent of the 
fistula, a narrow communication between the fistula and 
the intestine that may still have been present, a short, 
straight tract makes it impossible for the fibrin glue to be 
retained adequately in the tract for any length of time, 
technical problems due to lack of experience and a failure 
of antibiotics to eradicate all bacteria trapped in the clots in 
the fistula [6-13]. There were 6 early recurrences in this 
study. It was suspected that in recurrent cases, the most 
probable causes were considered to be misdiagnosis or in-
correct examination of the fistula tract preoperatively, 
technical problems, early oral intake postoperatively or in-
fection in the tract. We have also observed that short fistula 
tracts respond poorly to fibrin glue injections, and the fis-
tula tract length was approximately 4 cm in most of the re-
current cases. We found that the commercial fibrin glue 
succeeded more in cases longer than 4 cm with solitary fis-
tulas during the five-year follow-up period. We thought 
there might also be technical problems in first few cases 
due to a lack of experience. It was also thought that early 
postoperative oral intake and the prediction of an in-
fection in the tract might dislodge the fibrin glue plug. 
Two recurrent cases were also treated with second appli-
cations in this study. The total number of recurrences was 
17. Despite impressive early results, we saw the success 
rate drop at the end of the follow-up period. However, this 
result is good because fibrin glue  has many advantages, 
the most important of which is continence.    
Whether fibrin glue can cure all types of fistulae re-
mains controversial [11]. High anal fistulas are among the 
most difficult problems faced in colorectal surgery. A fistu-
lotomy is not advised for these fistulas, because treatment 
and continence are competing priorities, and fistulotomy 
leads to an unacceptable risk of incontinence. In this study, 
long solitary non-ramificate fistula tracts tended to show 
good results with fibrin glue. 
Fibrin glue in the treatment of fistulae-in-ano has been 
previously explored and the availability of commercial fi-
brin glue has also improved [3,16-18]. As a result, the suc-
cess and recurrences rates were thus considered to be 
acceptable. However, long-term results were lower than 
our preliminary results.
Fibrin glue represents a new option in the management 
of the various types of fistulas-in-ano [19,22]. It has en-
joyed recent success in a series of selected patients. 
Healing rates of up to 80 percent for cryptoglandular have 
also been reported (usually preliminary results). It can 
heal fistulas without jeopardizing anal continence, and if it 
fails, it can be repeated several times if required. Additio-
nally, it does not preclude or alter subsequent treatment 
options [19]. Our practice and results are also similar to 
those reported in the literature. 
In conclusion, fibrin glue injection is a feasible, valuable, 
effective treatment alternative in the management of fistu-
la-in-ano. This procedure is easy for surgeons to learn and 
perform. The most important advantage is avoiding the 
risk of complications associated with fistulotomy or other 
techniques. It is minimally invasive and allows for a re-
sumption of normal activities within a short time, for most 
patients. 
In this study, we reported a 63.04% success rate in clos-
ing fistulas-in-ano with a sphincter muscle-sparing techni-
que using fibrin glue over the long period. This technique 
has many advantages as mentioned above. This study also 
indicates that fibrin glue application is a simple, easily ap-
plicable, repeatable and safe for the treatment of fistu-
la-in-ano. Thereafter,  we should not only consider the suc-
cess rate of commercial fibrin glue but the very important  
 advantage of the muscle sparing techniques. It must be 
thought of as a preliminary option particularly for crypto-
glandular and long fistulas. We think that some points 
must be observed with fibrin glue in anorectal fistulas for 
success. The most important factors are: fistula to be cryp-
toglanduler, to be solitary and long tracted, to prepare the 
bowel completely, to apply single dose parenteral anti-
biotics preoperatively and followed by five days per oral 
at postoperative period, to restrict oral nutrition post-
operative first day and to feed after second day 
step-by-step, to forbid sitting bath, to scrape the gran-
ulation tissue with a knotted nylon tape or similar techni-
ques, to clean the tract with saline after curettage, and to Fibrin glue in the treatment of fistula-in-ano
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avoid technical failure during the preparation of fibrin 
glue back table.
However, future investigations may be necessary to de-
termine the most effective fibrin glue type and the optimal 
application technique to improve these results. Compara-
tive studies also must establish which technique is most 
suitable on first application. 
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